Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands
Go back to Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 279.44 +17.27 (6.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.17 | 52 Week High | $139.79 | |||
| Open | $259.35 | 52 Week Low | $82.07 | |||
| Day High | $282.53 | P/E | 649.86 | |||
| Day Low | $258.00 | EPS | $0.43 | |||
| Volume | 2,347,177 | |||||
